Target intelligence / Profile preview

Porin A (PorA) of Neisseria meningitidis (PorA)

Target
PorA
Molecular classification
Porin, Outer membrane protein, Bacterial surface antigen, Beta-barrel protein
01

Overview

Porin A (PorA) is a major class 1 outer membrane protein of Neisseria meningitidis, functioning as a cation-selective porin that facilitates the diffusion of small hydrophilic molecules across the bacterial outer membrane (UniProt P0A3S1; Massari et al., 2003, PubMed: 12644316). It is a key surface-exposed antigen and a primary target for the human immune response during infection and vaccination (Pollard et al., 2009, PubMed: 19740354). PorA is characterized by a 16-stranded beta-barrel structure with eight extracellular loops, where loops 1 and 4 (Variable Regions 1 and 2) are highly variable and contain the principal epitopes for neutralizing antibodies (Sacchi et al., 1998, PubMed: 9733631). Due to its high immunogenicity, PorA has been a central component in the development of outer membrane vesicle (OMV) vaccines, such as MeNZB and VA-MENGOC-BC, designed to control specific regional outbreaks of serogroup B meningococcal disease (O'Hallahan et al., 2004, PubMed: 15501601). However, the significant sequence diversity of PorA across different strains poses a major challenge for the development of a universal vaccine, as protection is typically strain-specific and requires matching the vaccine PorA subtype to the circulating strain (Tan et al., 2010, PubMed: 20637055).

Other names
Class 1 outer membrane proteinPorA proteinMajor outer membrane porin PorAMeningococcal PorA
02

Mechanism of action

Induction of host bactericidal antibodies that specifically target the surface-exposed variable loops (VR1 and VR2) of the PorA protein, facilitating complement-mediated lysis and opsonophagocytosis of Neisseria meningitidis (Pollard et al., 2009, PubMed: 19740354).

03

Biological functions

Nutrient transportIon transportMembrane permeabilityImmune evasionBacterial adhesion
04

Disease associations

Meningococcal diseaseMeningitisSepsisInfection
05

Safety considerations

Antigenic variation and sequence diversity in variable loopsStrain-specific immunity leading to limited cross-protectionPotential for vaccine escape through epitope shifting
06

Interacting drugs

MeNZB vaccine

3 more in the full profile.

07

Biomarkers

Serum bactericidal antibody (SBA) titerPorA genosubtype (VR1/VR2 sequence)PorA expression levels

Beyond the preview

Go deeper on Porin A (PorA) of Neisseria meningitidis (PorA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Porin A (PorA) of Neisseria meningitidis (PorA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call